Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benznidazole - Insud Pharma

Next Previous
Search
Drug Profile

Benznidazole - Insud Pharma

Latest Information Update: 17 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chemo Group
  • Developer Drugs for Neglected Diseases Initiative Foundation; Exeltis France; Exeltis USA; Insud Pharma; Mundo Sano
  • Class Acetamides; Antiprotozoals; Imidazoles
  • Mechanism of Action Free radical stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Chagas disease
  • New Molecular Entity No

Highest Development Phases

  • Marketed Chagas disease

Most Recent Events

  • 17 Jan 2025 Phase-III clinical development in Chagas disease (In children, In adults, In adolescents) is ongoing in Colombia, Bolivia, Argentina (PO) (NCT04024163)
  • 28 Aug 2021 No recent reports of development identified for phase-I development in Chagas-disease(In volunteers) in United Kingdom (PO, Tablet)
  • 31 Jul 2020 Phase-III clinical trials in Chagas disease (In children, In adults, In adolescents) in Colombia, Bolivia, Argentina (PO) (NCT04024163)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top